Lumexa Imaging Holdings Statistics
Total Valuation
LMRI has a market cap or net worth of $896.71 million. The enterprise value is $1.80 billion.
Important Dates
The next confirmed earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LMRI has 96.11 million shares outstanding.
| Current Share Class | 96.11M |
| Shares Outstanding | 96.11M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +8.46% |
| Owned by Insiders (%) | 1.46% |
| Owned by Institutions (%) | 33.87% |
| Float | 22.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.83 |
| PS Ratio | 0.88 |
| Forward PS | 0.83 |
| PB Ratio | 1.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 52.60 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.76 |
| EV / EBITDA | 19.59 |
| EV / EBIT | 34.93 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 1.64.
| Current Ratio | 1.27 |
| Quick Ratio | 1.17 |
| Debt / Equity | 1.64 |
| Debt / EBITDA | 8.15 |
| Debt / FCF | n/a |
| Interest Coverage | 0.44 |
Financial Efficiency
Return on equity (ROE) is -12.60% and return on invested capital (ROIC) is 2.14%.
| Return on Equity (ROE) | -12.60% |
| Return on Assets (ROA) | 1.88% |
| Return on Invested Capital (ROIC) | 2.14% |
| Return on Capital Employed (ROCE) | 3.25% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $243,591 |
| Profits Per Employee | -$11,215 |
| Employee Count | 4,335 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LMRI has paid $14.89 million in taxes.
| Income Tax | 14.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 11.71 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.20 |
| Average Volume (20 Days) | 878,063 |
Short Selling Information
The latest short interest is 3.89 million, so 4.05% of the outstanding shares have been sold short.
| Short Interest | 3.89M |
| Short Previous Month | 3.22M |
| Short % of Shares Out | 4.05% |
| Short % of Float | 17.67% |
| Short Ratio (days to cover) | 2.94 |
Income Statement
In the last 12 months, LMRI had revenue of $1.02 billion and -$47.10 million in losses. Loss per share was -$0.66.
| Revenue | 1.02B |
| Gross Profit | 157.57M |
| Operating Income | 51.58M |
| Pretax Income | -32.22M |
| Net Income | -47.10M |
| EBITDA | 91.96M |
| EBIT | 51.58M |
| Loss Per Share | -$0.66 |
Full Income StatementBalance Sheet
The company has $58.83 million in cash and $962.50 million in debt, with a net cash position of -$903.68 million or -$9.40 per share.
| Cash & Cash Equivalents | 58.83M |
| Total Debt | 962.50M |
| Net Cash | -903.68M |
| Net Cash Per Share | -$9.40 |
| Equity (Book Value) | 586.12M |
| Book Value Per Share | 6.10 |
| Working Capital | 48.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $17.07 million and capital expenditures -$23.48 million, giving a free cash flow of -$6.40 million.
| Operating Cash Flow | 17.07M |
| Capital Expenditures | -23.48M |
| Depreciation & Amortization | 40.38M |
| Net Borrowing | -383.52M |
| Free Cash Flow | -6.40M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
Gross margin is 15.40%, with operating and profit margins of 5.04% and -4.60%.
| Gross Margin | 15.40% |
| Operating Margin | 5.04% |
| Pretax Margin | -3.15% |
| Profit Margin | -4.60% |
| EBITDA Margin | 8.99% |
| EBIT Margin | 5.04% |
| FCF Margin | n/a |
Dividends & Yields
LMRI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -5.24% |
| FCF Yield | -0.71% |
Analyst Forecast
The average price target for LMRI is $20.75, which is 122.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.75 |
| Price Target Difference | 122.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 5.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LMRI has an Altman Z-Score of 1.08 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.08 |
| Piotroski F-Score | 3 |
